Biotech ETF Overview

With 16 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $14.93B. The average expense ratio is 0.76%. Biotech ETFs can be found in the following asset classes:

  • Equity

The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $6.84B in assets. In the last trailing year, the best performing Biotech ETF was the BIS at 9.94%. The most-recent ETF launched in the Biotech space was the Global X Genomics & Biotechnology ETF GNOM in 04/05/19.

TOP ETF PERFORMERS

LABD Direxion Daily S&P Biotech Bear 3X Shares 7.21%
LABD Direxion Daily S&P Biotech Bear 3X Shares 7.21%
BBH VanEck Vectors Biotech ETF 0.30%
BBH VanEck Vectors Biotech ETF 0.30%
ZBIO ProShares UltraPro Short Nasdaq Biotechnology 0.07%

BOTTOM ETF PERFORMERS

LABU Direxion Daily S&P Biotech Bull 3X Shares -12.58%
LABU Direxion Daily S&P Biotech Bull 3X Shares -12.58%
CHNA Loncar China BioPharma ETF -5.63%
CHNA Loncar China BioPharma ETF -5.63%
CNCR Loncar Cancer Immunotherapy ETF -5.42%

TOP CREATIONS

BIS ProShares UltraShort Nasdaq Biotechnology 2.58
BIS ProShares UltraShort Nasdaq Biotechnology 2.58
GNOM Global X Genomics & Biotechnology ETF 0.75
GNOM Global X Genomics & Biotechnology ETF 0.75
CNCR Loncar Cancer Immunotherapy ETF 0

TOP REDEMPTIONS

IBB iShares NASDAQ Biotechnology ETF -179.03
IBB iShares NASDAQ Biotechnology ETF -179.03
XBI SPDR S&P Biotech ETF -169.99
XBI SPDR S&P Biotech ETF -169.99
LABU Direxion Daily S&P Biotech Bull 3X Shares -32.78

AUM WINNERS

GNOM Global X Genomics & Biotechnology ETF 252.68%
GNOM Global X Genomics & Biotechnology ETF 252.68%
CHNA Loncar China BioPharma ETF 39.77%
CHNA Loncar China BioPharma ETF 39.77%
ZBIO ProShares UltraPro Short Nasdaq Biotechnology 6.74%

AUM LOSERS

BBP Virtus LifeSci Biotech Products ETF -14.97%
BBP Virtus LifeSci Biotech Products ETF -14.97%
UBIO ProShares UltraPro Nasdaq Biotechnology -8.97%
UBIO ProShares UltraPro Nasdaq Biotechnology -8.97%
BIB ProShares Ultra NASDAQ Biotechnology -7.91%

ETF Report

Sectors In Review: June 2019

Health care and real estate struggled during the month.

Features and News

How To Know What’s In Your ETF

Our free tools and resources can help with your due diligence efforts.

ETF Report

Smart Beta: Beyond The Hype

Despite all the buzz, advisors have reasons to be wary of such strategies.

Features and News

Politics Weigh On Health Care ETFs

Fears of Medicare-for-all are weighing on health care ETFs. Is this an opportunity?

Daily ETF Watch

ETF Week: Zero-Fee Funds Debut

Plus, the first space ETF rolls out.

Features and News

Worst Performing ETFs Of Q1 2019

These ETFs stand out for their poor performance in a strong year for financial markets.

ETF Report

Sectors In Review: April 2019

Sector ETFs had a mostly positive February.

ETF Report

2018 ETF.com Annual Awards

From the ETF of the Year to the People’s Choice ETF, we review the winners of each award, what drove their success and the finalists they competed against.

Features and News

CNBC ETF Edge: Biotech Getting Sick?

How you should trade biotech ETFs.